ArticleOncology letters2026

CD47 monoclonal antibody enhances the inhibitory effect of anti-HER2 chimeric antigen receptor macrophages on ovarian cancer.

Jie Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.